カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のグリピジド錠市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Glipizide Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23SM7864）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23SM7864
■ 発行日：2023年9月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：109
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のグリピジド錠市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界のグリピジド錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のグリピジド錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- グリピジド錠の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

グリピジド錠市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・2.5mg、5mg、10mg

用途別セグメント
・病院、薬局

主要な市場プレーヤー
・Pfizer、Teva、Novartis、Zhuhai United Laboratories、Heilongjiang Ruige Pharmaceutical、Guangdong Huanan Pharmaceutical Group、Jiangsu Pingguang Pharmaceutical、Tianjin Zhongtian Pharmaceutical、Suicheng Pharmaceutical、Harbin Pharmaceutical Group、Guizhou Shengjitang Pharmaceutical、Shandong Yikang Pharmaceutical、Reyoung Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、グリピジド錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なグリピジド錠メーカーの企業概要、2019年～2022年までのグリピジド錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なグリピジド錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別グリピジド錠の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのグリピジド錠のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのグリピジド錠市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびグリピジド錠の産業チェーンを掲載しています。
・第14、15章では、グリピジド錠の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– グリピジド錠の概要
– タイプ別分析（2018年vs2022年vs2029年）：2.5mg、5mg、10mg
– 用途別分析（2018年vs2022年vs2029年）：病院、薬局
– 世界のグリピジド錠市場規模・予測
– 世界のグリピジド錠生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、Teva、Novartis、Zhuhai United Laboratories、Heilongjiang Ruige Pharmaceutical、Guangdong Huanan Pharmaceutical Group、Jiangsu Pingguang Pharmaceutical、Tianjin Zhongtian Pharmaceutical、Suicheng Pharmaceutical、Harbin Pharmaceutical Group、Guizhou Shengjitang Pharmaceutical、Shandong Yikang Pharmaceutical、Reyoung Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：2.5mg、5mg、10mg
・用途別分析2018年-2029年：病院、薬局
・グリピジド錠の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・グリピジド錠のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・グリピジド錠のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・グリピジド錠の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・グリピジド錠の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Glipizide Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Glipizide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 2.5 mg
1.3.3 5mg
1.3.4 10mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Glipizide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Glipizide Tablets Market Size & Forecast
1.5.1 Global Glipizide Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Glipizide Tablets Sales Quantity (2018-2029)
1.5.3 Global Glipizide Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Glipizide Tablets Product and Services
2.1.4 Pfizer Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Glipizide Tablets Product and Services
2.2.4 Teva Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Glipizide Tablets Product and Services
2.3.4 Novartis Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments/Updates
2.4 Zhuhai United Laboratories
2.4.1 Zhuhai United Laboratories Details
2.4.2 Zhuhai United Laboratories Major Business
2.4.3 Zhuhai United Laboratories Glipizide Tablets Product and Services
2.4.4 Zhuhai United Laboratories Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Zhuhai United Laboratories Recent Developments/Updates
2.5 Heilongjiang Ruige Pharmaceutical
2.5.1 Heilongjiang Ruige Pharmaceutical Details
2.5.2 Heilongjiang Ruige Pharmaceutical Major Business
2.5.3 Heilongjiang Ruige Pharmaceutical Glipizide Tablets Product and Services
2.5.4 Heilongjiang Ruige Pharmaceutical Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Heilongjiang Ruige Pharmaceutical Recent Developments/Updates
2.6 Guangdong Huanan Pharmaceutical Group
2.6.1 Guangdong Huanan Pharmaceutical Group Details
2.6.2 Guangdong Huanan Pharmaceutical Group Major Business
2.6.3 Guangdong Huanan Pharmaceutical Group Glipizide Tablets Product and Services
2.6.4 Guangdong Huanan Pharmaceutical Group Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Guangdong Huanan Pharmaceutical Group Recent Developments/Updates
2.7 Jiangsu Pingguang Pharmaceutical
2.7.1 Jiangsu Pingguang Pharmaceutical Details
2.7.2 Jiangsu Pingguang Pharmaceutical Major Business
2.7.3 Jiangsu Pingguang Pharmaceutical Glipizide Tablets Product and Services
2.7.4 Jiangsu Pingguang Pharmaceutical Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Jiangsu Pingguang Pharmaceutical Recent Developments/Updates
2.8 Tianjin Zhongtian Pharmaceutical
2.8.1 Tianjin Zhongtian Pharmaceutical Details
2.8.2 Tianjin Zhongtian Pharmaceutical Major Business
2.8.3 Tianjin Zhongtian Pharmaceutical Glipizide Tablets Product and Services
2.8.4 Tianjin Zhongtian Pharmaceutical Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Tianjin Zhongtian Pharmaceutical Recent Developments/Updates
2.9 Suicheng Pharmaceutical
2.9.1 Suicheng Pharmaceutical Details
2.9.2 Suicheng Pharmaceutical Major Business
2.9.3 Suicheng Pharmaceutical Glipizide Tablets Product and Services
2.9.4 Suicheng Pharmaceutical Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Suicheng Pharmaceutical Recent Developments/Updates
2.10 Harbin Pharmaceutical Group
2.10.1 Harbin Pharmaceutical Group Details
2.10.2 Harbin Pharmaceutical Group Major Business
2.10.3 Harbin Pharmaceutical Group Glipizide Tablets Product and Services
2.10.4 Harbin Pharmaceutical Group Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
2.11 Guizhou Shengjitang Pharmaceutical
2.11.1 Guizhou Shengjitang Pharmaceutical Details
2.11.2 Guizhou Shengjitang Pharmaceutical Major Business
2.11.3 Guizhou Shengjitang Pharmaceutical Glipizide Tablets Product and Services
2.11.4 Guizhou Shengjitang Pharmaceutical Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Guizhou Shengjitang Pharmaceutical Recent Developments/Updates
2.12 Shandong Yikang Pharmaceutical
2.12.1 Shandong Yikang Pharmaceutical Details
2.12.2 Shandong Yikang Pharmaceutical Major Business
2.12.3 Shandong Yikang Pharmaceutical Glipizide Tablets Product and Services
2.12.4 Shandong Yikang Pharmaceutical Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shandong Yikang Pharmaceutical Recent Developments/Updates
2.13 Reyoung Pharmaceutical
2.13.1 Reyoung Pharmaceutical Details
2.13.2 Reyoung Pharmaceutical Major Business
2.13.3 Reyoung Pharmaceutical Glipizide Tablets Product and Services
2.13.4 Reyoung Pharmaceutical Glipizide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Reyoung Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Glipizide Tablets by Manufacturer
3.1 Global Glipizide Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Glipizide Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Glipizide Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Glipizide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Glipizide Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Glipizide Tablets Manufacturer Market Share in 2022
3.5 Glipizide Tablets Market: Overall Company Footprint Analysis
3.5.1 Glipizide Tablets Market: Region Footprint
3.5.2 Glipizide Tablets Market: Company Product Type Footprint
3.5.3 Glipizide Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Glipizide Tablets Market Size by Region
4.1.1 Global Glipizide Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Glipizide Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Glipizide Tablets Average Price by Region (2018-2029)
4.2 North America Glipizide Tablets Consumption Value (2018-2029)
4.3 Europe Glipizide Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Glipizide Tablets Consumption Value (2018-2029)
4.5 South America Glipizide Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Glipizide Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Glipizide Tablets Sales Quantity by Type (2018-2029)
5.2 Global Glipizide Tablets Consumption Value by Type (2018-2029)
5.3 Global Glipizide Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Glipizide Tablets Sales Quantity by Application (2018-2029)
6.2 Global Glipizide Tablets Consumption Value by Application (2018-2029)
6.3 Global Glipizide Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Glipizide Tablets Sales Quantity by Type (2018-2029)
7.2 North America Glipizide Tablets Sales Quantity by Application (2018-2029)
7.3 North America Glipizide Tablets Market Size by Country
7.3.1 North America Glipizide Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Glipizide Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Glipizide Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Glipizide Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Glipizide Tablets Market Size by Country
8.3.1 Europe Glipizide Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Glipizide Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Glipizide Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Glipizide Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Glipizide Tablets Market Size by Region
9.3.1 Asia-Pacific Glipizide Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Glipizide Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Glipizide Tablets Sales Quantity by Type (2018-2029)
10.2 South America Glipizide Tablets Sales Quantity by Application (2018-2029)
10.3 South America Glipizide Tablets Market Size by Country
10.3.1 South America Glipizide Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Glipizide Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Glipizide Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Glipizide Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Glipizide Tablets Market Size by Country
11.3.1 Middle East & Africa Glipizide Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Glipizide Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Glipizide Tablets Market Drivers
12.2 Glipizide Tablets Market Restraints
12.3 Glipizide Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Glipizide Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Glipizide Tablets
13.3 Glipizide Tablets Production Process
13.4 Glipizide Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Glipizide Tablets Typical Distributors
14.3 Glipizide Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Glipizide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Glipizide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Glipizide Tablets Product and Services
Table 6. Pfizer Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Glipizide Tablets Product and Services
Table 11. Teva Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Glipizide Tablets Product and Services
Table 16. Novartis Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Recent Developments/Updates
Table 18. Zhuhai United Laboratories Basic Information, Manufacturing Base and Competitors
Table 19. Zhuhai United Laboratories Major Business
Table 20. Zhuhai United Laboratories Glipizide Tablets Product and Services
Table 21. Zhuhai United Laboratories Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zhuhai United Laboratories Recent Developments/Updates
Table 23. Heilongjiang Ruige Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Heilongjiang Ruige Pharmaceutical Major Business
Table 25. Heilongjiang Ruige Pharmaceutical Glipizide Tablets Product and Services
Table 26. Heilongjiang Ruige Pharmaceutical Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Heilongjiang Ruige Pharmaceutical Recent Developments/Updates
Table 28. Guangdong Huanan Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 29. Guangdong Huanan Pharmaceutical Group Major Business
Table 30. Guangdong Huanan Pharmaceutical Group Glipizide Tablets Product and Services
Table 31. Guangdong Huanan Pharmaceutical Group Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Guangdong Huanan Pharmaceutical Group Recent Developments/Updates
Table 33. Jiangsu Pingguang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Pingguang Pharmaceutical Major Business
Table 35. Jiangsu Pingguang Pharmaceutical Glipizide Tablets Product and Services
Table 36. Jiangsu Pingguang Pharmaceutical Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Jiangsu Pingguang Pharmaceutical Recent Developments/Updates
Table 38. Tianjin Zhongtian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Tianjin Zhongtian Pharmaceutical Major Business
Table 40. Tianjin Zhongtian Pharmaceutical Glipizide Tablets Product and Services
Table 41. Tianjin Zhongtian Pharmaceutical Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Tianjin Zhongtian Pharmaceutical Recent Developments/Updates
Table 43. Suicheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Suicheng Pharmaceutical Major Business
Table 45. Suicheng Pharmaceutical Glipizide Tablets Product and Services
Table 46. Suicheng Pharmaceutical Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Suicheng Pharmaceutical Recent Developments/Updates
Table 48. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 49. Harbin Pharmaceutical Group Major Business
Table 50. Harbin Pharmaceutical Group Glipizide Tablets Product and Services
Table 51. Harbin Pharmaceutical Group Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Harbin Pharmaceutical Group Recent Developments/Updates
Table 53. Guizhou Shengjitang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Guizhou Shengjitang Pharmaceutical Major Business
Table 55. Guizhou Shengjitang Pharmaceutical Glipizide Tablets Product and Services
Table 56. Guizhou Shengjitang Pharmaceutical Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Guizhou Shengjitang Pharmaceutical Recent Developments/Updates
Table 58. Shandong Yikang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Shandong Yikang Pharmaceutical Major Business
Table 60. Shandong Yikang Pharmaceutical Glipizide Tablets Product and Services
Table 61. Shandong Yikang Pharmaceutical Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Shandong Yikang Pharmaceutical Recent Developments/Updates
Table 63. Reyoung Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Reyoung Pharmaceutical Major Business
Table 65. Reyoung Pharmaceutical Glipizide Tablets Product and Services
Table 66. Reyoung Pharmaceutical Glipizide Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Reyoung Pharmaceutical Recent Developments/Updates
Table 68. Global Glipizide Tablets Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Glipizide Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Glipizide Tablets Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Glipizide Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Glipizide Tablets Production Site of Key Manufacturer
Table 73. Glipizide Tablets Market: Company Product Type Footprint
Table 74. Glipizide Tablets Market: Company Product Application Footprint
Table 75. Glipizide Tablets New Market Entrants and Barriers to Market Entry
Table 76. Glipizide Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Glipizide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Glipizide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Glipizide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Glipizide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Glipizide Tablets Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Glipizide Tablets Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Glipizide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Glipizide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Glipizide Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Glipizide Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Glipizide Tablets Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Glipizide Tablets Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Glipizide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Glipizide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Glipizide Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Glipizide Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Glipizide Tablets Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Glipizide Tablets Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Glipizide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Glipizide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Glipizide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Glipizide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Glipizide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Glipizide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Glipizide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Glipizide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Glipizide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Glipizide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Glipizide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Glipizide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Glipizide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Glipizide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Glipizide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Glipizide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Glipizide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Glipizide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Glipizide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Glipizide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Glipizide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Glipizide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Glipizide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Glipizide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Glipizide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Glipizide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Glipizide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Glipizide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Glipizide Tablets Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Glipizide Tablets Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Glipizide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Glipizide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Glipizide Tablets Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Glipizide Tablets Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Glipizide Tablets Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Glipizide Tablets Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Glipizide Tablets Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Glipizide Tablets Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Glipizide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Glipizide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Glipizide Tablets Raw Material
Table 136. Key Manufacturers of Glipizide Tablets Raw Materials
Table 137. Glipizide Tablets Typical Distributors
Table 138. Glipizide Tablets Typical Customers
List of Figures
Figure 1. Glipizide Tablets Picture
Figure 2. Global Glipizide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Glipizide Tablets Consumption Value Market Share by Type in 2022
Figure 4. 2.5 mg Examples
Figure 5. 5mg Examples
Figure 6. 10mg Examples
Figure 7. Global Glipizide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Glipizide Tablets Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Pharmacy Examples
Figure 11. Global Glipizide Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Glipizide Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Glipizide Tablets Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Glipizide Tablets Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Glipizide Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Glipizide Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Glipizide Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Glipizide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Glipizide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Glipizide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Glipizide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Glipizide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Glipizide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Glipizide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Glipizide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Glipizide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Glipizide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Glipizide Tablets Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Glipizide Tablets Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Glipizide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Glipizide Tablets Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Glipizide Tablets Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Glipizide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Glipizide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Glipizide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Glipizide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Glipizide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Glipizide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Glipizide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Glipizide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Glipizide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Glipizide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Glipizide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Glipizide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 53. China Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Glipizide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Glipizide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Glipizide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Glipizide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Glipizide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Glipizide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Glipizide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Glipizide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Glipizide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Glipizide Tablets Market Drivers
Figure 74. Glipizide Tablets Market Restraints
Figure 75. Glipizide Tablets Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Glipizide Tablets in 2022
Figure 78. Manufacturing Process Analysis of Glipizide Tablets
Figure 79. Glipizide Tablets Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のグリピジド放出制御錠剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界のルラシドン塩酸塩錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のビルダグリプチン錠市場2023年：企業・地域・タイプ・用途別分析
  • 世界のペントキシフィリン徐放性錠剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界のイバブラジン塩酸塩錠市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23SM7864 )"世界のグリピジド錠市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Glipizide Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。